Inventor
Kenneth J. Ruterbories
Inventor
Indianapolis, IN, US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes20%
C07CAcyclic or carbocyclic compounds15%
C07KPeptides5%
PatentTitleYear
6,693,109'Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation'20046,528,534'Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation'20036,448,269'Glycoprotein IIb/IIIa antagonists'20026,291,469'Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation'20016,020,362'Glycoprotein IIB IIIA antagonists'20005,731,324'Glycoprotein IIb/IIIa antagonists'19985,436,229'Bisulfite adducts of arginine aldehydes'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1995–2004Patents assigned to LILLY CO ELI (7)· patent assignee history
1995–2004Based in Indianapolis, IN, US· patent location history
2001Patents assigned to COR THERAPEUTICS INC (1)· patent assignee history
2003–2004Patents assigned to MILLENNIUM PHARM INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| LILLY CO ELI | 7 | 1995–2004 |
| MILLENNIUM PHARM INC | 2 | 2003–2004 |
| COR THERAPEUTICS INC | 1 | 2001 |
Locations
| Location | Patents | Span |
|---|---|---|
| Indianapolis, IN, US | 7 | 1995–2004 |